SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-009050
Filing Date
2023-02-28
Accepted
2023-02-28 06:55:31
Documents
13
Period of Report
2023-02-23
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT brhc10048710_8k.htm   iXBRL 8-K 31026
  Complete submission text file 0001140361-23-009050.txt   219234

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmy-20230223.xsd EX-101.SCH 4696
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20230223_def.xml EX-101.DEF 18374
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20230223_lab.xml EX-101.LAB 28469
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20230223_pre.xml EX-101.PRE 20673
7 EXTRACTED XBRL INSTANCE DOCUMENT brhc10048710_8k_htm.xml XML 8433
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 23678295
SIC: 2834 Pharmaceutical Preparations